Arnold and Mabel Beckman Foundation

Arnold and Mabel Beckman Foundation

Arnold O. Beckman and Mabel Meinzer Beckman established the foundation in 1977 after the sale of Beckman Instruments. The endowment continues to honor their focus on scientific instrumentation and discovery. The foundation allocates across public markets, real estate, and venture capital. Confirmed holdings include positions in Blackstone Real Estate Partners VII and a 2024 addition to a biotech asset portfolio intended to reduce inflation sensitivity. Geographic exposure centers on the United States with secondary commitments that reach global markets. Capital is deployed primarily through fund commitments rather than direct co-investments. The organization employs 45 professionals at its Irvine headquarters. It maintains membership in the Council on Foundations and the Orange County Funders Roundtable. In 2024 the foundation added biotechnology holdings to its endowment. External advisors include Martlet Asset Management and Simon Quick Advisors. The foundation operates with a hybrid model that pairs a permanent endowment with a separate grant-making mandate. This structure channels investment returns directly into five named research institutes and young-investigator programs without creating additional operating companies or family succession vehicles.